Aspire Biopharma Holdings, Inc. has filed 214 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-07-20 | Other Events |
| SC 13G | 2026-07-02 | Beneficial Ownership Report (Passive) |
| 8-K | 2026-06-22 | Submission of Matters to a Vote of Security Holders |
| 8-K | 2026-06-12 | Other Events |
| 8-K | 2026-06-12 | Entry into a Material Definitive Agreement; Regulation FD Disclosure |
| SC 13G | 2026-05-15 | Beneficial Ownership Report (Passive) |
| 10-Q | 2026-05-15 | Quarterly Report |
| 8-K | 2026-05-14 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits |
| SC 13G/A | 2026-05-13 | Beneficial Ownership Report (Passive, Amended) |
| DEFR14A | 2026-05-12 | Revised Definitive Proxy Statement |